| 2025 |
Menz, B. D., Modi, N. D., Abuhelwa, A. Y., Kuderer, N. M., Lyman, G. H., Swain, S. M., . . . Hopkins, A. M. (2025). Patient-reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials. International Journal of Cancer, 157(10), 2135-2145. DOI Scopus1 Europe PMC2 |
| 2025 |
Modi, N. D., Li, L. X., Logan, J. M., Wiese, M. D., Abuhelwa, A. Y., McKinnon, R. A., . . . Hopkins, A. M. (2025). The state of individual participant data sharing for the highest-revenue medicines. Clinical Trials, 22(2), 170-177. DOI |
| 2025 |
Menz, B. D., Modi, N. D., Abuhelwa, A. Y., Ruanglertboon, W., Vitry, A., Gao, Y., . . . Hopkins, A. M. (2025). Generative AI Chatbots for Reliable Cancer Information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models. European Journal of Cancer, 218, 115274-1-115274-6. DOI Scopus11 WoS11 Europe PMC6 |
| 2025 |
Chu, B., Modi, N. D., Menz, B. D., Bacchi, S., Kichenadasse, G., Paterson, C., . . . Hopkins, A. M. (2025). Generative AI’s healthcare professional role creep: a cross-sectional evaluation of publicly accessible, customised health-related GPTs. Frontiers in Public Health, 13, 1584348-1-1584348-8. DOI Scopus2 WoS1 |
| 2025 |
Modi, N. D., Menz, B. D., Awaty, A. A., Alex, C. A., Logan, J. M., McKinnon, R. A., . . . Hopkins, A. M. (2025). Assessing the system-instruction vulnerabilities of large language models to malicious conversion into health disinformation chatbots. Annals of Internal Medicine, 178(8), 1172-1180. DOI Scopus4 Europe PMC3 |
| 2025 |
Modi, N. D., Abuhelwa, A. Y., Kuderer, N. M., Li, L. X., Lyman, G. H., Koczwara, B., . . . Hopkins, A. M. (2025). Associations of commonly used concomitant medications with survival and adverse event outcomes in breast cancer. Cancer Medicine, 14(21, article no. e71320), 1-10. DOI Europe PMC1 |
| 2025 |
Modi, N. D. (2025). Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023. American College of Cardiology. Journal, online(22), 1-77. DOI Scopus33 Europe PMC8 |
| 2024 |
Menz, B. D., Kuderer, N. M., Bacchi, S., Modi, N. D., Chin-Yee, B., Hu, T., . . . Hopkins, A. M. (2024). Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis. BMJ, 384(e078538), e078538-1-e078538-10. DOI Scopus64 WoS56 Europe PMC43 |
| 2024 |
Modi, N. D., Swain, S. M., Buyse, M., Kuderer, N. M., Rowland, A., Rockhold, F. W., . . . Hopkins, A. M. (2024). Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration–Approved Anticancer Drugs: A Call for Systematic Data Availability. Journal of Clinical Oncology, 42(32), 3773-3777. DOI Scopus6 Europe PMC7 |
| 2024 |
Hopkins, A. M., Modi, N. D., Rockhold, F. W., Hoffmann, T., Menz, B. D., Veroniki, A. A., . . . Sorich, M. J. (2024). Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation. Journal Of Clinical Epidemiology, 167(111263), 1-9. DOI Scopus5 Europe PMC3 |
| 2024 |
Menz, B. D., Modi, N. D., Sorich, M. J., & Hopkins, A. M. (2024). Health disinformation use case highlighting the urgent need for artificial intelligence vigilance: weapons of mass disinformation. JAMA Internal Medicine, 184(1), 92-96. DOI Scopus63 Europe PMC41 |
| 2024 |
Almansour, S. A., Alqudah, M. A. Y., Abuhelwa, Z., Al Shamsi, H. O., Alhuraiji, A., Semreen, M. H., . . . Abuhelwa, A. Y. (2024). Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials. Therapeutic Advances in Medical Oncology, 16, 1-14. DOI Scopus1 |
| 2023 |
Modi, N. D., Kichenadasse, G., Hoffmann, T. C., Haseloff, M., Logan, J. M., Veroniki, A. A., . . . Hopkins, A. M. (2023). A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies. BMC Medicine, 21(1), 400. DOI Scopus17 Europe PMC12 |
| 2023 |
Hopkins, A. M., Modi, N. D., Abuhelwa, A. Y., Kichenadasse, G., Kuderer, N. M., Lyman, G. H., . . . Sorich, M. J. (2023). Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data Packages. JAMA Oncology, 9(12), 1621-1626. DOI Scopus14 Europe PMC12 |
| 2023 |
Modi, N., Abuhelwa, A. Y., Rowland, A., Menz, B. D., McKinnon, R. A., Sorich, M. J., & Hopkins, A. M. (2023). Association between patient-reported outcomes and therapeutic outcomes in patients with breast cancer: A pooled individual-participant data analysis.. Journal of Clinical Oncology, 41(16_suppl), 530. DOI |
| 2022 |
Modi, N. D., Abuhelwa, A. Y., Mckinnon, R. A., Boddy, A. V., Haseloff, M., Wiese, M. D., . . . Hopkins, A. M. (2022). Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration. JAMA Oncology, 8(9), 1310-1316. DOI Scopus17 Europe PMC17 |
| 2022 |
Tan, E., Abuhelwa, A. Y., Badaoui, S., Modi, N. D., Wiese, M. D., Mckinnon, R. A., . . . Hopkins, A. M. (2022). Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with Atezolizumab. Bladder Cancer, 8(1), 81-88. DOI Scopus7 Europe PMC7 |
| 2022 |
Modi, N. D., Danell, N. O., Perry, R. N. A., Abuhelwa, A. Y., Rathod, A., Badaoui, S., . . . Hopkins, A. M. (2022). Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer. ESMO Open, 7(3, article no. 100475), 1-8. DOI Scopus14 Europe PMC12 |
| 2021 |
Modi, N. D., Tan, J. Q. E., Rowland, A., Koczwara, B., Abuhelwa, A. Y., Kichenadasse, G., . . . Hopkins, A. M. (2021). The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data. Npj Breast Cancer, 7(1), 30. DOI Scopus41 Europe PMC33 |
| 2021 |
Modi, N. D., Abuhelwa, A. Y., Menz, B. D., McKinnon, R. A., Sorich, M. J., & Hopkins, A. M. (2021). Commentary: Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology, 12, 732622. DOI Scopus1 Europe PMC1 |
| 2021 |
Modi, N. D., Abuhelwa, A. Y., Badaoui, S., Shaw, E., Shankaran, K., McKinnon, R. A., . . . Hopkins, A. M. (2021). Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib. The Breast, 58, 57-62. DOI Scopus14 Europe PMC10 |
| 2020 |
Ang, F. L. I., Rowland, A., Modi, N. D., McKinnon, R. A., Sorich, M. J., & Hopkins, A. M. (2020). Early adverse events predict survival outcomes in HER2-positive advanced breast cancer patients treated with Lapatinib plus Capecitabine. Journal of Cancer, 11(11), 3327-3333. DOI Scopus5 WoS5 Europe PMC5 |
| 2020 |
Hopkins, A. M., Wagner, J., Kichenadasse, G., Modi, N., Rowland, A., & Sorich, M. J. (2020). Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy. International Journal of Cancer, 147(11), 3085-3089. DOI Scopus34 Europe PMC27 |
| 2020 |
Modi, N. D., Sorich, M. J., Rowland, A., McKinnon, R. A., Koczwara, B., Wiese, M. D., & Hopkins, A. M. (2020). Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine. Clinical Breast Cancer, 20(2), e220-e228. DOI Scopus15 Europe PMC13 |
| 2020 |
Modi, N. D., Sorich, M. J., Rowland, A., Logan, J. M., McKinnon, R. A., Kichenadasse, G., . . . Hopkins, A. M. (2020). A literature review of treatment-specific clinical prediction models in patients with breast cancer. Critical Reviews in Oncology Hematology, 148(102908), 8 pages. DOI Scopus15 WoS12 Europe PMC11 |
| 2020 |
Modi, N. D., Tan, J. Q. E., Rowland, A., Koczwara, B., Kichenadasse, G., McKinnon, R. A., . . . Hopkins, A. M. (2020). The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data. Frontiers in Oncology, 10(1130), 1130. DOI Scopus13 Europe PMC11 |
| 2019 |
Jin, C., Alenazy, R., Wang, Y., Mowla, R., Qin, Y., Tan, J. Q. E., . . . Ma, S. (2019). Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance. Bioorganic and Medicinal Chemistry Letters, 29(7), 882-889. DOI Scopus15 WoS13 Europe PMC10 |